Approval · Notice of Compliance 20729 · 2018
CYSTADANE: Notice of Compliance 20729
Issued April 11, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20729
- Date
- April 11, 2018
- Company
- Recordati Rare Diseases Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in Product Ownership and Updates to the Product Labelling
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSTADANE | 02238526 | Marketed |
Medicinal ingredients
- BETAINE 1 G per SCOOP